LCI - Lannett Co. Inc.

felixbocharov

felixbocharov

Lannett Company, Inc. engages in the development, manufacture, packaging, marketing, and distribution of generic versions of pharmaceutical products in the United States. Its products portfolio primarily comprises Acetazolamide for glaucoma; Butalbital, Aspirin, and Caffeine capsules to treat migraine headache; Clindamycin HCl capsules, Doxycyline tablets, Sulfamethoxazole w/ Trimethoprim, and Doxycyline Hyclate tablets used as antibiotics; Danazol capsules for endometriosis; Dicyclomine tablets/capsules for irritable bowels; Digoxin tablets used to treat congestive heart failure in patients of various ages and demographic backgrounds; and Diphenoxylate with atropine sulfate tablets to treat diarrhea. The company also offers Hydromorphone HCL tablets, Morphine Sulfate oral solution, and Oxycodone HCl oral solution to treat pain; Phentermine HCL tablets to treat weight loss; Pilocarpine tablets for dryness of the mouth; Primidone tablets for epilepsy; Levothyroxine Sodium and Unithroid tablets to treat hypothyroidism and other thyroid disorders; Methocarbamol tablets and Baclofen tablets for muscle relaxation; Methyltestoterone/Esterified Estrogens tablets for hormone replacement; Terbutaline Sulfate tablets for bronchospasms; and Probenecid tablets for gout. Lannett sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, and health maintenance organizations. It has an agreement with PharmaSeed Bioservices, Ltd. to develop a tropical pharmaceutical product. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.

Shares Outstanding: 24.17M
Float: 10.06M
 
heavy volume, may have put in a near term bottom today, let's see if we can get some momentum tomorrow, plenty of upside
 
Both LCI and Kremers have great pipelines. FDA approvals are eminent. They can happen any day now. With the Kremers acquisition, LCI is a much stronger company. Be assured, they will make up the loss of the customer and LCI will be huge going forward. As investors, the average guys , like us, do.
 
Is the party finally over for shorts? They can still cover now and make a huge profit.I'd certainly cover, plenty other stocks to short
 
You must log in or register to reply here.
Back
Top